Cargando…

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma

BACKGROUND: Liver transplantation (LT) has been performed in a select group of patients presenting with unresectable or primary sclerosing cholangitis (PSC)-associated perihilar cholangiocarcinoma (pCCA) in the Mayo Clinic with a reported 5-year overall survival (OS) of 53% on intention-to-treat ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vugts, Jaynee J. A., Gaspersz, Marcia P., Roos, Eva, Franken, Lotte C., Olthof, Pim B., Coelen, Robert J. S., van Vugt, Jeroen L. A., Labeur, Tim A., Brouwer, Lieke, Besselink, Marc G. H., IJzermans, Jan N. M., Darwish Murad, Sarwa, van Gulik, Thomas M., de Jonge, Jeroen, Polak, Wojciech G., Busch, Olivier R. C., Erdmann, Joris L., Groot Koerkamp, Bas, Buettner, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Hepatobiliary Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892510/ https://www.ncbi.nlm.nih.gov/pubmed/32901308 http://dx.doi.org/10.1245/s10434-020-09001-8

Ejemplares similares

The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma
por: van Keulen, Anne-Marleen, et al.
Publicado: (2023)

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy
por: Coelen, Robert J. S., et al.
Publicado: (2016)

Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma
por: Gaspersz, Marcia P., et al.
Publicado: (2019)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
por: Olthof, Pim B., et al.
Publicado: (2020)

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group
por: Ruzzenente, Andrea, et al.
Publicado: (2021)

Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Holster, Jessica J., et al.
Publicado: (2022)

Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2012)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
por: Jachs, Mathias, et al.
Publicado: (2023)

Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
por: Ayez, Ninos, et al.
Publicado: (2011)

Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis
por: Coelen, Robert J. S., et al.
Publicado: (2016)

The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis
por: Qin, Tingting, et al.
Publicado: (2022)

Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma
por: Franken, L. C., et al.
Publicado: (2020)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

The natural course of giant paraesophageal hernia and long-term outcomes following conservative management
por: Oude Nijhuis, Renske A B, et al.
Publicado: (2020)

Author response to: Comment on: Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
por: Buettner, Stefan, et al.
Publicado: (2023)

Prediction of Early Recurrence After Surgery for Liver Tumor (ERASL): An International Validation of the ERASL Risk Models
por: Beumer, Berend R., et al.
Publicado: (2021)

Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review
por: Franken, L. C., et al.
Publicado: (2019)

Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study
por: Kuipers, H., et al.
Publicado: (2020)

ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery—Portal Vein Embolization
por: Olthof, Pim B., et al.
Publicado: (2020)

Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial
por: Wiggers, Jimme K, et al.
Publicado: (2015)

Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making
por: de Jong, David M., et al.
Publicado: (2023)

The Landmark Series: Minimally Invasive Pancreatic Resection
por: van Hilst, Jony, et al.
Publicado: (2020)

Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1
por: Biewenga, Maaike, et al.
Publicado: (2021)

Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
por: Hoogwater, Frederik J H, et al.
Publicado: (2023)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

Can we predict the future of patients with liver cirrhosis using volumetrics?
por: Lantinga, Marten A., et al.
Publicado: (2022)

Questionnaire PLD‐complaint‐specific assessment identifies need for therapy in polycystic liver disease: A multi‐centric prospective study
por: Billiet, Antoon, et al.
Publicado: (2023)

Clinical management of chronic hepatitis B: A concise overview
por: Furquim d’Almeida, Arno, et al.
Publicado: (2021)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study
por: Ruys, Anthony T., et al.
Publicado: (2011)

Occurrence of seeding metastases in resectable perihilar cholangiocarcinoma and the role of low-dose radiotherapy to prevent this
por: Franken, Lotte C, et al.
Publicado: (2020)

A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas
por: Demols, Anne, et al.
Publicado: (2023)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey
por: Driessen, Stan, et al.
Publicado: (2023)

International external validation of a stratification tool to identify branch‐duct intraductal papillary mucinous neoplasms at lowest risk of progression
por: Overbeek, Kasper A., et al.
Publicado: (2022)

Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function
por: Rassam, F., et al.
Publicado: (2019)

Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021)

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis
por: Klompmaker, Sjors, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1vvd5st568b7kfig3gh8a7pl6c